Solid-state form of amg 706 and pharmaceutical compositions thereof -> Monitor Keywords
Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
site info Site News  |  monitor Monitor Keywords  |  monitor archive Monitor Archive  |  organizer Organizer  |  account info Account Info  |  
05/08/08 - USPTO Class 514 |  268 views | #20080108664 | Prev - Next | About this Page  514 rss/xml feed  monitor keywords

Solid-state form of amg 706 and pharmaceutical compositions thereof

Title: Solid-state form of amg 706 and pharmaceutical compositions thereof




Brief Patent Description - Full Patent Description - Patent Claims

The Patent Description & Claims data below is from USPTO Patent Application 20080108664, Solid-state form of amg 706 and pharmaceutical compositions thereof.


1. An amorphous form of a compound wherein said compound is AMG706.

2. The amorphous form of claim 1, wherein said amorphous form exhibits a glass transition measurable by differential scanning calorimetry.

3. The amorphous form of claim 1 wherein said amorphous form exhibits a differential scanning calorimetry thermogram glass transition at about 110.degree. C.

4. The amorphous form of claim 1 wherein said amorphous form exhibits a differential scanning calorimetry thermogram exotherm between about 150.degree. C. to about 160.degree. C.

5. A pharmaceutical composition comprising amorphous AMG 706 in a total AMG 706 dosage amount of about 25 mg to about 200 mg, and one or more pharmaceutically acceptable excipients, wherein said amorphous AMG 706 exhibits a glass transition measurable by differential scanning calorimetry.

6. Amorphous AMG 706 prepared by a lyophilization method.

7. Amorphous AMG 706 prepared by a spray drying method.

Brief Patent Description - Full Patent Description - Patent Claims

Click on the above for other options relating to this Solid-state form of amg 706 and pharmaceutical compositions thereof patent application.

Patent Applications in related categories:

20090291981 - 5-lipoxygenase-activating protein inhibitor - Described herein is the FLAP inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxy-pyridin-3-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the FLAP inhibitor, or a pharmaceutically acceptable salt thereof, including solvates, and polymorphs thereof. Also described herein are pharmaceutical compositions suitable for administration to a mammal that include the FLAP ...


###
monitor keywords

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Solid-state form of amg 706 and pharmaceutical compositions thereof or other areas of interest.
###


Previous Patent Application:
Cyclopropyl piperidine glycine transporter inhibitors
Next Patent Application:
Heteroaryl (substituted)alkyl n-substituted sulfoximines as insecticides
Industry Class:
Drug, bio-affecting and body treating compositions

###

FreshPatents.com Support
Thank you for viewing the Solid-state form of amg 706 and pharmaceutical compositions thereof patent info.
IP-related news and info


Results in 0.30452 seconds


Other interesting Feshpatents.com categories:
Software:  Finance AI Databases Development Document Navigation Error 174
filepatents (1K)

* Protect your Inventions
* US Patent Office filing
patentexpress PATENT INFO